Regenerative medicine
PRP, stem cells, exosomes and the alternatives ranked by trial evidence for joints, tendons, backs and recovery.
Topic overview →Which regenerative medicine treatments work best for joint pain?
For joint pain the treatments that work best are ranked by randomised evidence, and the honest ranking puts the non-regenerative options first: structured exercise therapy (the strongest evidence for pain and function in osteoarthritis of any intervention), weight loss where weight is a factor (including GLP-1 agonists, which reduced knee osteoarthritis pain substantially in a randomised trial), and short-term corticosteroid injections for flares. Among regenerative treatments, autologous chondrocyte implantation (MACI) is approved and effective — for focal cartilage defects in younger patients, not for osteoarthritis; platelet-rich plasma has modest evidence in knee osteoarthritis that is better against hyaluronic acid than against placebo; hyaluronic-acid injections give small, short-lived benefit; bone-marrow and adipose 'stem cell' injections have not beaten placebo consistently in randomised trials; exosome and IV 'stem cell' products have no controlled evidence and documented harms. My advice: exercise and weight first, a steroid injection for a flare, PRP as a reasonable trial if you want an injectable and understand the limits, and no cell product outside a trial or an approved indication.
PharmD-reviewed · Updated
What is the most effective regenerative medicine for knees?
The most effective regenerative medicine for a knee depends on what is wrong with it, and for the commonest problem — osteoarthritis — the most effective treatments are not regenerative. Ranked by diagnosis: for knee osteoarthritis, structured exercise (strongest evidence of any intervention), weight loss with semaglutide where obesity is present (a randomised trial showed large pain reduction), a corticosteroid injection for flares, and PRP as a modest adjunct; hyaluronic acid gives small brief benefit; bone-marrow and adipose 'stem cell' injections have not beaten placebo consistently and are not approved. For a focal cartilage defect in a younger knee, autologous chondrocyte implantation (MACI) is approved and outperforms microfracture — the one genuinely effective regenerative knee treatment, for that indication only. For a degenerative meniscal tear, exercise therapy matches arthroscopic surgery in randomised trials; for a ligament injury, rehabilitation with or without reconstruction depending on instability. Exosomes and clinic 'stem cell' products have no evidence for any knee diagnosis. Get the diagnosis first; the most effective treatment follows from it.
PharmD-reviewed · Updated
Which regenerative medicine options help avoid joint replacement?
The options that genuinely help avoid or delay joint replacement are ranked by how much they preserve function and postpone surgery in trials, and the top of the list is not regenerative: structured exercise and weight loss (including semaglutide where obesity is present) delay progression and the need for surgery more than any injection; offloading braces and footwear help medial knee osteoarthritis; high tibial osteotomy realigns a younger, active knee and postpones replacement by a decade in many patients; and autologous chondrocyte implantation (MACI) repairs focal cartilage defects before they become arthritis — the one regenerative option with evidence for preventing later surgery, in that narrow indication. Corticosteroid injections buy weeks; PRP buys modest months in some; bone-marrow and adipose 'stem cell' injections have not been shown to delay replacement or regrow cartilage; exosomes have no evidence. The honest caveat: joint replacement has excellent outcomes and its results are worse when it is delayed past the point of severe functional loss — so the goal is to avoid an unnecessary replacement, not to avoid a necessary one.
PharmD-reviewed · Updated
What regenerative medicine is best for chronic back pain?
For chronic low back pain, the treatments that work best in randomised trials are not injections of any kind: graded exercise, cognitive-behavioural and pain-education approaches, and multidisciplinary rehabilitation reduce pain and disability more durably than anything injected; staying active beats rest; and for the minority with a clear structural cause, targeted procedures have evidence — radiofrequency ablation for facet-joint pain confirmed by diagnostic blocks, basivertebral nerve ablation for vertebrogenic pain with specific MRI changes, and decompression for nerve compression with matching symptoms. Regenerative injections rank low: intradiscal PRP has one small positive trial and larger null ones; intradiscal and facet 'stem cell' injections have not beaten placebo in the controlled trials that exist and no product is approved; prolotherapy has small inconsistent trials; exosomes have no evidence. Epidural steroids help sciatica for weeks, not chronic axial pain. Spinal fusion for non-specific back pain is no better than intensive rehabilitation in randomised trials. My advice: a structured exercise and psychological programme first, a diagnosis-specific procedure only when the diagnosis is confirmed, and no regenerative injection outside a trial.
PharmD-reviewed · Updated
Which regenerative medicine therapy is safest for arthritis patients?
The safest therapies for an arthritis patient are the ones whose harms are known, small and reversible — and ranked on that, the safest regenerative option is PRP (autologous, low-risk, modest benefit), which still sits below the non-regenerative treatments with the best safety records: structured exercise, weight loss, topical NSAIDs and, for a flare, a single corticosteroid injection. Hyaluronic acid is safe and of little value. MACI is safe within its narrow indication because it is manufactured under pharmaceutical controls. GLP-1 agonists are safe in their indicated population with known gastrointestinal and muscle-loss effects. Oral NSAIDs are the commonest source of serious harm in arthritis — kidney, cardiovascular, gastrointestinal, and interactions with anticoagulants and blood-pressure drugs. At the bottom on safety: bone-marrow and adipose 'stem cell' injections (unregulated preparations, no approval, infections documented), exosomes (unverified, regulator warnings) and clinic cell products (blindness, tumours, sepsis and a death in the published record). For rheumatoid, psoriatic and other inflammatory arthritis the safety question is different again: the safe and effective therapy is disease-modifying medication from a rheumatologist, and regenerative injections have no role and can delay it. Safe means known; nothing sold as regenerative for arthritis is known.
PharmD-reviewed · Updated
Best regenerative medicine treatments for osteoarthritis relief without surgery.
Osteoarthritis relief without surgery comes from a programme rather than a product, and the components rank by how much relief they deliver and how long it lasts: a supervised exercise programme first (the largest and most durable effect of any non-surgical treatment); weight loss second, with semaglutide where obesity is present (a randomised trial showed a large fall in knee pain); topical NSAIDs for daily pain with a fraction of the tablet's risk; offloading braces, footwear and a cane for a single worn compartment; a corticosteroid injection for a flare that stops the programme; duloxetine for widespread pain sensitisation; PRP as a modest, low-risk adjunct once the programme is running; hyaluronic acid for small brief relief; and, at the bottom, bone-marrow and adipose 'stem cell' injections that have not beaten placebo and exosomes with no evidence. The regenerative injections are the least of the programme, not the centre of it. Assembled in that order over twelve weeks, most people with osteoarthritis get relief that lasts; the ones who do not are the ones for whom surgery is the right next step.
PharmD-reviewed · Updated
Best regenerative medicine options for tendon and ligament injuries.
For tendon and ligament injuries the best-evidenced treatment is progressive loading — eccentric and heavy slow resistance exercise — which outperforms every injection in the tendinopathies that have been trialled, and the regenerative options rank by tendon rather than by product: PRP has reasonable randomised evidence in chronic lateral epicondylitis (tennis elbow) and some in patellar tendinopathy, was no better than placebo in a well-run Achilles tendinopathy trial, and has inconsistent results in rotator cuff disease; corticosteroid injections relieve tendon pain for weeks and produce worse outcomes at a year than doing nothing; shockwave therapy has modest evidence in calcific shoulder, plantar fascia and some insertional tendinopathies; needle tenotomy is low-risk with small trials; surgery is for ruptures and for recalcitrant cases after loading fails. For ligaments, rehabilitation is the treatment, reconstruction is for instability, and PRP adds nothing in trials of the anterior cruciate ligament. Stem-cell injections have no controlled evidence in any tendon or ligament and exosomes none at all. Load the tendon, be patient, use PRP where the trials say it helps, and refuse the steroid unless the plan is a short bridge.
PharmD-reviewed · Updated
Best non-surgical regenerative medicine therapies for knee cartilage damage.
No non-surgical therapy regrows knee cartilage — MRI outcomes in the controlled trials of PRP, hyaluronic acid and cell injections show no cartilage regeneration — so the best non-surgical therapies for cartilage damage are ranked on what they actually do: protect the remaining cartilage, offload it, and relieve the pain. In that order: quadriceps and hip strengthening (reduces joint load and symptoms, the strongest evidence); weight loss including semaglutide where obesity is present (reduces load with every step and pain in a randomised trial); offloading with an unloader brace or cane for single-compartment damage; activity modification that keeps the joint moving without impact overload; PRP as a modest symptomatic adjunct with no structural effect; hyaluronic acid for brief relief; a single steroid injection for a flare, never a series, because steroids accelerate cartilage loss; and, at the bottom, bone-marrow and adipose cell injections that have not changed cartilage on MRI and exosomes with no evidence. The honest truth is that the regenerative options for cartilage are surgical — autologous chondrocyte implantation for a focal defect, osteotomy to offload a compartment — and a non-surgical programme is what protects the cartilage until, and often instead of, either.
PharmD-reviewed · Updated
Best regenerative medicine solution to speed up sports injury recovery.
The regenerative solution that speeds sports injury recovery most is early, progressive, criteria-based loading — the treatment with the strongest evidence for faster return to play and lower re-injury in muscle, tendon and ligament injuries — and the injectables rank below it by injury: PRP in acute hamstring strains did not shorten return to play in the well-run randomised trials; PRP in chronic tennis elbow and possibly the patellar tendon helps recovery that has stalled; PRP in acute ligament sprains and in ACL reconstruction added nothing; blood-flow-restriction training accelerates strength recovery when full loading is not yet possible; hyperbaric oxygen has no consistent evidence; stem-cell injections have no controlled evidence for any sports injury; and the peptides sold to athletes — BPC-157, TB-500 — have no human trials and are banned in competition. The honest answer is that recovery is sped up by loading earlier and more precisely, not by injecting something, and that the fastest-looking shortcut — a steroid or a rushed return — raises the re-injury rate that costs the most time of all.
PharmD-reviewed · Updated
Best evidence-based regenerative medicine therapy for chronic joint pain.
Ranked strictly on randomised trials with the joint, the population and the outcome named, the best evidence-based therapies for chronic joint pain are: structured exercise (dozens of trials in knee and hip osteoarthritis; pain and function; durable); weight loss, with semaglutide in obesity (a 68-week randomised trial: large reduction in knee pain versus placebo); topical NSAIDs (randomised trials in knee and hand osteoarthritis); autologous chondrocyte implantation (randomised against microfracture for focal cartilage defects — the one regenerative therapy with an A); duloxetine (randomised trials in osteoarthritis pain with central sensitisation); corticosteroid injection (short-term relief in trials; cartilage loss with repetition in a two-year trial); PRP (meta-analyses of knee osteoarthritis trials: modest benefit over hyaluronic acid, inconsistent over placebo; the largest placebo-controlled trial null on pain and MRI); hyaluronic acid (many trials; small effect judged not clinically important by several guidelines); mesenchymal cell injections (randomised trials inconsistent; better-controlled ones null; no approval); exosomes (no trials). 'Evidence-based regenerative therapy for chronic joint pain' therefore names exactly one therapy for one indication — MACI for a cartilage defect — and a modest adjunct, PRP, for the rest. The evidence-based treatment of chronic joint pain is mostly not regenerative, and it works.
PharmD-reviewed · Updated
The Longevity Brief
One evidence-graded email a week: what is new in longevity research, what is hype, and the one change actually worth making.
Free · one email a week · unsubscribe anytime.